Michael O Childress

7PUBLICATIONS
36CO-AUTHORS
Molecular targetsCancer diagnosisHaematological tumoursCancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Sep 15, 2025
Screening FDA-Approved Oncology Drugs with Three-Dimensional Spheroids Identifies Romidepsin as a Therapeutic Candidate for Osteosarcoma.

Emily E Seiden, Spencer M Richardson, Leah A Everitt

|May 19, 2025
Diagnosis and Classification of Primary Nodal Lymphomas in Dogs: A Consensus of the Oncology-Pathology Working Group.

Michael O Childress, Anne Avery, Erica Behling-Kelly

|Sep 01, 2024
MicroRNAs implicated in canine diffuse large B-cell lymphoma prognosis.

Nelly O Elshafie, Michael Gribskov, Nathanael I Lichti

|Jan 18, 2023
Serum thymidine kinase 1 activity as a prognostic biomarker in dogs with chemotherapy-treated diffuse large B-cell lymphoma.

Bushra Zaidi, Abhijit Mukhopadhyay, José A Ramos-Vara

Pageof 2